Treatment with IP-10 induces host-protective immune response by regulating the T regulatory cell functioning in Leishmania donovani-infected mice

Med Microbiol Immunol. 2011 Nov;200(4):241-53. doi: 10.1007/s00430-011-0197-y. Epub 2011 May 1.

Abstract

Visceral leishmaniasis (VL), caused by the protozoan parasite, Leishmania donovani, is characterized by an infection in the liver and spleen. The failure of the first-line drugs has led to the development of new strategies for combating VL. Recently, our group has shown that interferon-γ-inducible protein (IP)-10, a CXC chemokine, renders protection against VL. In the present study, we have elucidated the mechanism by which IP-10 renders protection in in vivo L. donovani infection. We observed that IP-10-treated parasitized BALB/c mice showed a strong host-protective T helper cell (Th) 1 immune response along with marked decrease in immunosuppressive cytokines, tumor growth factor (TGF)-β, and interleukin (IL)-10 secreting CD4(+) T cells. This IP-10-mediated decrease in immunosuppressive cytokines was correlated with the reduction in the elevated frequency of CD4(+)CD25(+) T regulatory (Treg) cells along with the reduced TFG-β production from these Treg cells in Leishmania-infected mice. This reduction in TGF-β production was due to effective modulation of TGF-β signaling by IP-10, which reduced the immunosuppressive activity of Treg cells. Thus, these findings put forward a detailed mechanistic insight into IP-10-mediated regulation of the Treg cell functioning during experimental VL, which might be helpful in combating Leishmania-induced pathogenesis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antiprotozoal Agents / pharmacology
  • Benzamides / administration & dosage
  • Benzamides / pharmacology
  • Cell Proliferation
  • Cells, Cultured
  • Chemokine CXCL10 / administration & dosage
  • Chemokine CXCL10 / pharmacology*
  • Coculture Techniques
  • Cytokines / immunology
  • Dioxoles / administration & dosage
  • Dioxoles / pharmacology
  • Flow Cytometry
  • Immunity, Cellular*
  • Leishmania donovani / immunology*
  • Leishmania donovani / pathogenicity
  • Leishmaniasis, Visceral / immunology
  • Leishmaniasis, Visceral / parasitology
  • Leishmaniasis, Visceral / therapy*
  • Mice
  • Mice, Inbred BALB C
  • Phosphorylation
  • Signal Transduction
  • Smad4 Protein / immunology
  • Smad4 Protein / metabolism
  • T-Lymphocytes, Helper-Inducer / immunology
  • T-Lymphocytes, Regulatory / drug effects
  • T-Lymphocytes, Regulatory / immunology*

Substances

  • 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide
  • Antiprotozoal Agents
  • Benzamides
  • Chemokine CXCL10
  • Cytokines
  • Dioxoles
  • Smad4 Protein
  • Smad4 protein, mouse